Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MYBPC2 and MYL1 as Significant Gene Markers for Rhabdomyosarcoma

1 Jan 2021

Abstract excerpt

Background: Rhabdomyosarcoma is the most common soft tissue tumor in children. Rhabdomyosarcoma commonly results in pain and bleeding caused by tumor compression and is prone to early metastasis and recurrence, which can seriously affect the therapeutic outcomes and long-term prognosis. Up to 37.7% of rhabdomyosarcomas may metastasize. Therefore, the molecular mechanisms underlying rhabdomyosarcoma must be...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Tumor Diagnosis and Treatments
Share to Chromatin Remodeling and Cancer
Share to Sarcoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33499774
DOI: 10.1177/1533033820979669

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MYBPC2 and MYL1 as Significant Gene Markers for RhabdomyosarcomaPMID 33499774Read ↗

Bioinformatics Prediction and Experimental Verification Identify MAD2L1 and CCNB2 as Diagnostic Biomarkers of RhabdomyosarcomaSemantic proximity Read ↗

CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysisSemantic proximity Read ↗

The current landscape of rhabdomyosarcomas: an update.Semantic proximity Read ↗

Rhabdomyosarcoma: Updates on classification and the necessity of molecular testing beyond immunohistochemistry.Semantic proximity Read ↗

Childhood RhabdomyosarcomaSemantic proximity Read ↗

Biological Role and Clinical Implications of MYOD1L122R Mutation in RhabdomyosarcomaSemantic proximity Read ↗

Probing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems.Semantic proximity Read ↗

Update on molecular findings in rhabdomyosarcomaSemantic proximity Read ↗

Advances in pediatric rhabdomyosarcoma characterization and disease model development.Semantic proximity Read ↗

Molecular diagnostics in the management of rhabdomyosarcomaSemantic proximity Read ↗

Second Malignant Neoplasms in Patients with Rhabdomyosarcoma: A US Population-Based AnalysisSemantic proximity Read ↗

An Integrative Morphologic and Molecular Approach for Diagnosis and Subclassification of Rhabdomyosarcoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.